Market Overview:
The global respiratory infection diagnostic market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of respiratory infections, rising demand for advanced diagnostic tests, and growing awareness about respiratory infections. Based on type, the global respiratory infection diagnostic market is segmented into microbiology, PCR, NGS, and immunoassay. The microbiology segment is expected to account for the largest share of the global respiratory infection diagnostic market in 2018. This segment is further divided into viral diagnostics and bacterial diagnostics. The viral diagnostics sub-segment is expected to grow at a higher CAGR than the bacterial diagnostics sub-segment during the forecast period from 2018 to 2030 owing to increasing incidence of viral respiratory infections across the globe.
Product Definition:
A respiratory infection is a type of infection that affects the respiratory system, which includes the nose, throat, larynx, bronchi and lungs. Respiratory infections can be caused by viruses, bacteria or other organisms. They can cause a variety of symptoms including coughing, sneezing, fever and chest congestion.
Microbiology:
Microbiology is the study of microorganisms, their growth, development and behavior. Microbiology also deals with diseases caused by these organisms. Respiratory infection is an inflammation of the lungs due to an infectious agent such as a virus or bacteria.
PCR:
Polymerase Chain Reaction (PCR) is a technique that uses DNA as a probe to identify and measure genetic material. It is used in molecular biology for the amplification of specific DNA sequences. The technology has been applied to clinical testing with remarkable success, leading to its routine use in medical diagnosis.
Application Insights:
Based on the application, the global respiratory infection diagnostic market is segmented into hospital lab, outpatient lab and others. Hospital labs held a major share in 2017 owing to presence of key players such as Quest Diagnostics and Laboratory Corporation of America. Quest Diagnostics is one of the largest providers for clinical diagnostics services for respiratory diseases along with other infectious diseases. It has more than 200 laboratories worldwide which offer point-of-care testing options through its assays line called Fast Track tests. The company also offers research studies to validate its products but does not have a wide range of product offerings in low cost settings like Europe or Asia Pacific regions due to high costs associated with research studies and development activities.
The out patient lab segment is expected to grow at fastest rate during forecast period due to increasing demand for rapid test options that are sensitive enough even without prior specimen preparation by using Nucleic Acid Test (NAT) based techniques such as Polymerase Chain Reaction (PCR).
Regional Analysis:
North America dominated the global respiratory infection diagnostic market in 2017. This can be attributed to favorable reimbursement policies, increasing prevalence of COVID-19 and other respiratory infections, and rising demand for rapid diagnostic tests. The U.S., which is at the forefront of this regional market, has one of the highest per capita healthcare spending along with a well-developed healthcare infrastructure that enables easy access to advanced technologies such as NGS platforms for diagnosis purposes.
Growth Factors:
- Increasing incidence of respiratory infections
- Rising demand for rapid and accurate diagnosis of respiratory infections
- Growing awareness about the benefits of early diagnosis and treatment of respiratory infections
- Technological advancements in respiratory infection diagnostic methods
- increasing funding for research on respiratory infection diagnostic methods
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Infection Diagnostic Market Research Report
By Type
Microbiology, PCR, NGS, Immunoassay
By Application
Hospital Lab, Outpatient Lab
By Companies
Ador Diagnostics, BD Diagnostics, Co-Diagnostics, Diagenode Diagnostics, GenePOC Diagnostics, Veradus Labs, Immunexpress, Janssen Diagnostics, Lumos Diagnostics, Oxford Nanopore, Prominex, Roche Molecular Diagnostics, SkylineDx, T2 Biosystems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
207
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Infection Diagnostic Market Report Segments:
The global Respiratory Infection Diagnostic market is segmented on the basis of:
Types
Microbiology, PCR, NGS, Immunoassay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Lab, Outpatient Lab
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ador Diagnostics
- BD Diagnostics
- Co-Diagnostics
- Diagenode Diagnostics
- GenePOC Diagnostics
- Veradus Labs
- Immunexpress
- Janssen Diagnostics
- Lumos Diagnostics
- Oxford Nanopore
- Prominex
- Roche Molecular Diagnostics
- SkylineDx
- T2 Biosystems
Highlights of The Respiratory Infection Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microbiology
- PCR
- NGS
- Immunoassay
- By Application:
- Hospital Lab
- Outpatient Lab
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Infection Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A respiratory infection diagnostic is a test that helps to determine the cause of respiratory illness. This can include tests for viruses, bacteria, and other organisms.
Some of the key players operating in the respiratory infection diagnostic market are Ador Diagnostics, BD Diagnostics, Co-Diagnostics, Diagenode Diagnostics, GenePOC Diagnostics, Veradus Labs, Immunexpress, Janssen Diagnostics, Lumos Diagnostics, Oxford Nanopore, Prominex, Roche Molecular Diagnostics, SkylineDx, T2 Biosystems.
The respiratory infection diagnostic market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Respiratory Infection Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Respiratory Infection Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Respiratory Infection Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Respiratory Infection Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Respiratory Infection Diagnostic Market Size & Forecast, 2018-2028
4.5.1 Respiratory Infection Diagnostic Market Size and Y-o-Y Growth
4.5.2 Respiratory Infection Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Respiratory Infection Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Respiratory Infection Diagnostic Market Size Forecast by Type
5.2.1 Microbiology
5.2.2 PCR
5.2.3 NGS
5.2.4 Immunoassay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Respiratory Infection Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Respiratory Infection Diagnostic Market Size Forecast by Applications
6.2.1 Hospital Lab
6.2.2 Outpatient Lab
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Respiratory Infection Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Respiratory Infection Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Respiratory Infection Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America Respiratory Infection Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Respiratory Infection Diagnostic Market Size Forecast by Type
9.6.1 Microbiology
9.6.2 PCR
9.6.3 NGS
9.6.4 Immunoassay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Respiratory Infection Diagnostic Market Size Forecast by Applications
9.10.1 Hospital Lab
9.10.2 Outpatient Lab
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Respiratory Infection Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe Respiratory Infection Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Respiratory Infection Diagnostic Market Size Forecast by Type
10.6.1 Microbiology
10.6.2 PCR
10.6.3 NGS
10.6.4 Immunoassay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Respiratory Infection Diagnostic Market Size Forecast by Applications
10.10.1 Hospital Lab
10.10.2 Outpatient Lab
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Respiratory Infection Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Respiratory Infection Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Respiratory Infection Diagnostic Market Size Forecast by Type
11.6.1 Microbiology
11.6.2 PCR
11.6.3 NGS
11.6.4 Immunoassay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Respiratory Infection Diagnostic Market Size Forecast by Applications
11.10.1 Hospital Lab
11.10.2 Outpatient Lab
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Respiratory Infection Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America Respiratory Infection Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Respiratory Infection Diagnostic Market Size Forecast by Type
12.6.1 Microbiology
12.6.2 PCR
12.6.3 NGS
12.6.4 Immunoassay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Respiratory Infection Diagnostic Market Size Forecast by Applications
12.10.1 Hospital Lab
12.10.2 Outpatient Lab
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Respiratory Infection Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Respiratory Infection Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Respiratory Infection Diagnostic Market Size Forecast by Type
13.6.1 Microbiology
13.6.2 PCR
13.6.3 NGS
13.6.4 Immunoassay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Respiratory Infection Diagnostic Market Size Forecast by Applications
13.10.1 Hospital Lab
13.10.2 Outpatient Lab
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Respiratory Infection Diagnostic Market: Competitive Dashboard
14.2 Global Respiratory Infection Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ador Diagnostics
14.3.2 BD Diagnostics
14.3.3 Co-Diagnostics
14.3.4 Diagenode Diagnostics
14.3.5 GenePOC Diagnostics
14.3.6 Veradus Labs
14.3.7 Immunexpress
14.3.8 Janssen Diagnostics
14.3.9 Lumos Diagnostics
14.3.10 Oxford Nanopore
14.3.11 Prominex
14.3.12 Roche Molecular Diagnostics
14.3.13 SkylineDx
14.3.14 T2 Biosystems
